BIOLARGO, INC. (BLGO) — Current Report

AI-Powered SEC Filing Analysis

Latest Current Report Filed: 2026-05-06

Key Insights

CEO Dennis P. Calvert conducted a town hall session on Discord on May 5, 2026, indicating the company is actively engaging with retail investors through alternative communication channels rather than traditional investor relations methods.
The filing is purely a Regulation FD Disclosure (Item 7.01) with no material business developments, financial results, or strategic announcements reported, suggesting this is routine investor communication rather than significant corporate news.
The company explicitly disclaimed liability for the disclosed information under Securities Act provisions, stating it is not 'filed' for purposes of Section 18 and will not be incorporated into future SEC filings, limiting the legal weight of statements made during the town hall.

Want the newest filings?

This analysis covers the filing from 2026-05-06. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Earlier Current Report filings

Filed: 2026-03-25

BioLargo, Inc. has entered into a $10 million common stock purchase agreement with Clearthink Capital Partners, LLC, providing the company with additional funding and flexibility to support its operations and growth.
The agreement allows BioLargo to sell shares to Clearthink at its discretion over a 36-month period, subject to certain limitations and conditions, including the effectiveness of a related registration statement.
The proceeds from these share sales will be used for working capital and general corporate purposes, potentially supporting the company's ongoing development and commercialization efforts.

Filed: 2026-03-05

BioLargo, Inc. announced plans to present a slide deck at an investor conference on March 5, 2026, providing an opportunity for the company to share updates and insights with the investment community.
The company also published a press release on March 5, 2026, potentially highlighting important developments or milestones that could impact the stock's performance.
As an OTCQX-listed company, BioLargo's share price and trading activity may be influenced by investor sentiment and market reaction to the information disclosed in the 8-K filing.

Other reports for BIOLARGO, INC.

Insider Trading Annual Report

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.